Table 1.
Description of clinicopathological factors in the Canary prostate cancer cohort.
| Characteristic | N = 10251 |
|---|---|
| Grade Group (GG) | |
| 1 | 400 (40%) |
| 2 | 381 (38%) |
| ≥3 | 223 (22%) |
| Unknown | 21 |
| Seminal Vesicle Invasion (SVI) | |
| Absent | 930 (93%) |
| Present | 71 (7.1%) |
| Unknown | 24 |
| Extraprostatic Extension (EPE) | |
| Absent | 700 (70%) |
| Present | 302 (30%) |
| Unknown | 23 |
| Surgical Margin | |
| Absent | 666 (68%) |
| Present | 312 (32%) |
| Unknown | 47 |
| Lymph Node Invasion | |
| Absent | 658 (95%) |
| Present | 32 (4.6%) |
| Unknown | 335 |
| Pre-Op PSA (ng/ml) | |
| Median | 6.4 |
| IQR | 4.8 – 9.5 |
| Unknown | 112 |
| Metastasis | |
| Absent | 875 (86%) |
| Present | 141 (14%) |
| Unknown | 9 |
| Metastasis-free Survival (yrs) | |
| Median | 6.4 |
| IQR | 4.7 – 8.4 |
| Unknown | 30 |
| Recurrence-free Survival (yrs) | 5.0 |
| Median | 5 |
| IQR | 1.1 – 7 |
| Unknown | 27 |
| Recurrence | |
| Absent | 559 (55%) |
| Present | 457 (45%) |
| Unknown | 9 |
1
Statistics presented: n (%); IQR: Interquartile Range